system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, RESULTS. Meshes: Action Potentials, Adenosine Triphosphate, Animals, Benzamides, Cardiotonic Agents, Diazoxide, In Vitro Techniques, Membrane Proteins, Mice, Mice, Inbred C57BL, Mice, Knockout, Mitochondria, Heart, Myocardial Contraction, Myocardial Ischemia, Myocardial Reperfusion, Myocardial Stunning, Potassium Channel Blockers, Potassium Channels, Potassium Channels, Inwardly Rectifying, Recovery of Function, Sarcolemma.
user
Is cardioprotective effect of diazoxide mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice? Context: We recently demonstrated that the sarcolemmal ATP-sensitive potassium (sarcK(ATP)) channel plays a key role in cardioprotection against ischemia/reperfusion injuries in Kir6.2-knockout (KO) mice. In the present study, we evaluated the effects of diazoxide, a mitochondrial ATP-sensitive potassium (mitoK(ATP)) channel opener, on ischemia-induced myocardial stunning in sarcK(ATP) channel-deficient mice. Langendorff-perfused hearts of wild-type (WT) and KO mice were subjected to global ischemia/reperfusion. Diazoxide improved the recovery of contractile function in WT hearts but not in KO hearts. Treatment with HMR1098 (a sarcK(ATP) channel blocker) but not 5-hydroxydecanoate (a mitoK(ATP) channel blocker) abolished the cardioprotective effect of diazoxide in WT hearts. In coronary-perfused WT ventricular muscle preparations, action potential shortening during ischemia was accelerated in the presence of diazoxide.
assistant
Diazoxide enhances action potential shortening during ischemia by activating sarcK(ATP) channels and provides cardioprotection in mouse hearts. Final Decision: yes